엘리 릴리 앤 컴퍼니
AT ˙ WBAG ˙ US5324571083
€981.00 ↑47.20 (5.05%)
2026-06-04
주가
SecurityAT:LLYC / Eli Lilly and Company
InstitutionRogco, Lp
Latest Disclosed Ownership572 shares
Latest Disclosed Value $ 526,108
Rogco, Lp reports 0.88% increase in ownership of LLYC / Eli Lilly and Company

On May 4, 2026 - Rogco, Lp filed a 13F-HR form disclosing ownership of 572 shares of Eli Lilly and Company (AT:LLYC) valued at $452,738 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 567 shares of Eli Lilly and Company. This represents a change in shares of 0.88% during the quarter. The current value of the position is $561,132 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F Eli Lilly COM 532457108 572 5 0.88 526 -13.63 0.1756
2026-01-30 2025-12-31 13F Eli Lilly COM 532457108 567 78 15.95 609 63.27 0.2018
2025-10-30 2025-09-30 13F Eli Lilly COM 532457108 489 477 3,975.00 373 4,044.44 0.1311
2025-07-18 2025-06-30 13F Eli Lilly COM 532457108 12 0 0.00 9 0.00 0.0035
2025-04-30 2025-03-31 13F Eli Lilly COM 532457108 12 0 0.00 10 0.00 0.0040
2025-01-31 2024-12-31 13F Eli Lilly COM 532457108 12 0 0.00 9 -10.00 0.0038
2024-10-23 2024-09-30 13F Eli Lilly COM 532457108 12 0 0.00 11 0.00 0.0042
2024-08-14 2024-06-30 13F Eli Lilly COM 532457108 12 0 0.00 11 11.11 0.0044
2024-05-08 2024-03-31 13F Eli Lilly COM 532457108 12 0 0.00 9 50.00 0.0038
2024-02-06 2023-12-31 13F Eli Lilly COM 532457108 12 -8 -40.00 7 -40.00 0.0031
2023-11-14 2023-09-30 13F Eli Lilly COM 532457108 20 20 11 0.0053
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.